198 related articles for article (PubMed ID: 30982573)
1. Clinical characteristics and outcomes of benign, atypical, and malignant breast adenomyoepithelioma: a single institution's experience.
Wiens N; Hoffman DI; Huang CY; Nayak A; Tchou J
Am J Surg; 2020 Apr; 219(4):651-654. PubMed ID: 30982573
[TBL] [Abstract][Full Text] [Related]
2. Breast adenomyoepithelioma and adenomyoepithelioma with carcinoma (malignant adenomyoepithelioma) with associated breast malignancies: A case series emphasizing histologic, radiologic, and clinical correlation.
Moritz AW; Wiedenhoefer JF; Profit AP; Jagirdar J
Breast; 2016 Oct; 29():132-9. PubMed ID: 27494340
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological characteristics and outcomes of malignant adenomyoepithelioma of the breast: a single institution's experience.
Alqudaihi HMA; Lee SB; Son BH; Ahn SH; Lee JW; Ko BS; Kim HJ; Chung IY; Kim J; Gong G
World J Surg Oncol; 2022 Apr; 20(1):128. PubMed ID: 35459179
[TBL] [Abstract][Full Text] [Related]
4. Malignant adenomyoepithelioma of the breast: A case report.
Zhang Z; Wang Y; Xie X; Peng J; Hong J; Bi L; Yang M
Medicine (Baltimore); 2021 Feb; 100(5):e24461. PubMed ID: 33592899
[TBL] [Abstract][Full Text] [Related]
5. Malignant Adenomyoepithelioma of the Breast and Associated Epithelial-Myoepithelial Carcinoma; A Rare Case Report.
Jameel Z; Kiluk J; Rosa M
Int J Surg Pathol; 2022 Aug; 30(5):569-573. PubMed ID: 35138180
[TBL] [Abstract][Full Text] [Related]
6. Adenomyoepithelioma with a human epidermal growth factor receptor 2-fluorescence in situ hybridization-confirmed ductal carcinoma in situ component: A case report and review of the literature.
Amano Y; Sakaguchi-Tamba M; Sasaki Y; Oshiro H; Fukushima N; Fujita T; Masuda S; Niki T
Medicine (Baltimore); 2020 Oct; 99(42):e22665. PubMed ID: 33080708
[TBL] [Abstract][Full Text] [Related]
7. Malignant adenomyoepithelioma of the breast: A case report.
Lari EA; Lari AA; Alsaeed T
Int J Surg Case Rep; 2020; 72():56-58. PubMed ID: 32506031
[TBL] [Abstract][Full Text] [Related]
8. Adenomyoepithelioma of the breast: a proposal for classification.
Rakha E; Tan PH; Ellis I; Quinn C
Histopathology; 2021 Oct; 79(4):465-479. PubMed ID: 33829532
[TBL] [Abstract][Full Text] [Related]
9. Malignant adenomyoepithelioma with multifocal adenosquamous carcinoma of the breast: A case report.
Hempenstall LE; Saxena M; Donaldson E
Breast J; 2019 Jul; 25(4):731-732. PubMed ID: 31062450
[No Abstract] [Full Text] [Related]
10. Adenomyoepithelioma of the breast with malignant transformation and repeated local recurrence: A case report.
Oda G; Nakagawa T; Mori M; Fujioka T; Onishi I
World J Clin Cases; 2021 Oct; 9(29):8864-8870. PubMed ID: 34734068
[TBL] [Abstract][Full Text] [Related]
11. Adenomyoepithelioma of the breast: a review stressing its propensity for malignant transformation.
Hayes MM
J Clin Pathol; 2011 Jun; 64(6):477-84. PubMed ID: 21307156
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic challenges of adenomyoepithelioma: A case report.
Pankratjevaite L; Lind K; Mele M; Lelkaitis G
Breast Dis; 2022; 41(1):325-330. PubMed ID: 35811510
[TBL] [Abstract][Full Text] [Related]
13. Adenomyoepithelioma of the breast with late pulmonary metastases - case report and review of the literature.
Korolczuk A; Amarowicz M; Bąk K; Korobowicz E; Koncewicz T
J Cardiothorac Surg; 2016 Aug; 11(1):121. PubMed ID: 27487934
[TBL] [Abstract][Full Text] [Related]
14. Malignant adenomyoepithelioma of the breast with matrix production may be compatible with one variant form of matrix-producing carcinoma: a case report.
Oka K; Sando N; Moriya T; Yatabe Y
Pathol Res Pract; 2007; 203(8):599-604. PubMed ID: 17658224
[TBL] [Abstract][Full Text] [Related]
15. HRAS is a therapeutic target in malignant chemo-resistant adenomyoepithelioma of the breast.
Bièche I; Coussy F; El-Botty R; Vacher S; Château-Joubert S; Dahmani A; Montaudon E; Reyes C; Gentien D; Reyal F; Ricci F; Nicolas A; Marchio C; Vincent-Salomon A; Laé M; Marangoni E
J Hematol Oncol; 2021 Sep; 14(1):143. PubMed ID: 34496925
[TBL] [Abstract][Full Text] [Related]
16. Malignant adenomyoepithelioma of the breast.
Moro K; Sakata E; Nakahara A; Hashidate H; Gabriel E; Makino H
Surg Case Rep; 2020 May; 6(1):118. PubMed ID: 32472226
[TBL] [Abstract][Full Text] [Related]
17. Benign Adenomyoepithelioma of the Breast: A Case Report and Review of Imaging Features.
Kovacs TA; Mourad SN; Dakkak A; Burger M; Edison M
Cureus; 2024 Apr; 16(4):e58421. PubMed ID: 38756318
[TBL] [Abstract][Full Text] [Related]
18. Establishment and characterization of organoids from a patient with adenomyoepithelioma of the breast.
Luo X; She J; Xu T; Zhou Y; Xu C; Jiang J; Li T; Liu H; Shen H; Yin B; Dai B
Bioengineered; 2021 Dec; 12(2):11578-11585. PubMed ID: 34874791
[TBL] [Abstract][Full Text] [Related]
19. Adenomyoepithelial tumors of the breast: molecular underpinnings of a rare entity.
Ginter PS; McIntire PJ; Kurtis B; Mirabelli S; Motanagh S; Hoda S; Elemento O; Shin SJ; Mosquera JM
Mod Pathol; 2020 Sep; 33(9):1764-1772. PubMed ID: 32355271
[TBL] [Abstract][Full Text] [Related]
20. Clinical presentation, national practice patterns, and outcomes of breast adenomyoepithelioma.
Haque W; Verma V; Suzanne Klimberg V; Nangia J; Schwartz M; Brian Butler E; Teh BS
Breast J; 2020 Apr; 26(4):653-660. PubMed ID: 31578797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]